Pharmaceutical corporations in India have appealed for a reduction in the Goods and Services Tax (GST) on essential medications to ensure that they are affordable for the general population. Anil Matai, the Director General of the Organisation of Pharmaceutical Producers of India (OPPI), conveyed the industry’s desired outcomes for the upcoming Union Budget 2024. He […]